Use of substituted 2-aminotetralines for the preventative treatment of Parkinson's disease

Details for Australian Patent Application No. 2004308649 (hide)

Owner Schwarz Pharma AG

Inventors Scheller, Dieter; Dressen, Frank

Agent Davies Collison Cave

Pub. Number AU-B-2004308649

PCT Pub. Number WO2005/063238

Priority 103 61 258.0 24.12.03 DE

Filing date 23 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 26 August 2010

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/063238 Priority application(s): WO2005/063238

26 August 2010 Application Accepted

  Published as AU-B-2004308649

25 November 2010 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH 2005

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308652-Method for producing formaldehyde

2004308648-Use of rotigotine for the treatment or prevention of dopaminergic neurone loss